Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4725 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
filingDate |
2013-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2020-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2020-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-102062640-B1 |
titleOfInvention |
Heteraryl-ketone fused azadecalin glucocorticoid receptor modulators |
abstract |
The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using such compounds as glucocorticoid receptor modulators. In some embodiments, the present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of formula (I). In some embodiments, the present invention provides a method of modulating a glucocorticoid receptor, comprising contacting a glucocorticoid receptor with a compound of formula (I) to modulate the glucocorticoid receptor, and antagonizing the glucocorticoid receptor. A method of treating a disease via a method comprising treating the disease by administering a therapeutically effective amount of a compound of formula (I) to a subject in need thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648245-B2 |
priorityDate |
2012-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |